000 04413nam a2200409 i 4500
999 _c362715
_d362715
_x1
001 362715
003 ES-MaUEC
005 20230102121608.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 210922s2021 sz | o |||| 0|eng d
020 _a9783030787370
024 7 _a10.1007/978-3-030-78737-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280.L5
_b2021 EB
245 0 0 _aLiver Cancer in the Middle East
_cedited by Brian I. Carr
250 _aFirst edition 2021
264 1 _aCham
_bSpringer International Publishing
_c2021
300 _a1 recurso en línea (XV, 414 páginas)
_b42 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
505 0 _aBiological Aspects of HCC -- Changing Etiology and Epidemiology of Human Liver Cancer -- Hepatocarcinogenesis Induced by Environmental -- Exposures in the Middle East -- Obesity and Hepatocellular Carcinoma : Epidemiology and Mechanisms -- Epidemiology of Hepatitis B Virus in the Middle East -- Hepatocellular Carcinoma in the United Arab Emirates -- Overview of Clinical HCC and its Management -- Cost Effective -- Therapies for HCC: Resection and Ablation -- Transarterial Radioembolization in Hepatocellular Carcinoma -- Intra-arterial Chemotherapy and -- Transarterial Chemoembolization in Hepatocellular Carcinoma -- Radiotherapy for Hepatocellular Carcinoma -- Liver Transplantation in Middle East -- Individual Patient Assessment and Therapy Decision-Making in a Live Donor-Based Liver Transplant Institute -- Hepatocellular Cancer in Iran -- Hepatocellular Carcinoma In Kuwait -- Insights on Hepatocellular carcinoma in Saudi Arabia -- Hepatitis C induced Hepatocellular Carcinoma in the Middle East -- Hepatocellular Carcinoma in the Middle East: An Overview -- Current HCC Clinical and Research in Egypt -- Hepatocellular Carcinoma in Turkey - A Review of Disease Epidemiology and Treatment Outcomes -- Targeting c-Met and AXL Crosstalk for the Treatment of Hepatocellular Carcinoma -- Hepatocellular Carcinoma in Morocco -- Hepatocellular Carcinoma in Lebanon and its Association with Thalassemia -- An Overview of Hepatocellular Carcinoma (HCC) in Lebanon: a focus on hepatitis B and thalassemia-related HCC -- Hepatocellular Carcinoma in Pakistan: An Update -- Future Directions -- The Need for Region-Wide HCC Collaborations.
520 _aThis book aims to illuminate the causes, incidence, and treatments of Hepatocellular Carcinoma(HCC) or liver cancer in the politically important and societally diverse region of the Middle East. Taking a flexible and inclusive view, it examines the influences of geography, crops and diet, ethnicity, and local behavior on both diagnosis and outcomes of this disease. Understanding the different causes of liver cancer enables effective strategies for both prevention and early diagnosis while knowledge of the different treatment modalities, their uses and limitations, availability and costs, works to inform rational treatment provision and selection. Divided into four sections, this book considers the causes and clinical syndromes associated with HCC, provides a detailed overview of clinical HCC and treatment modalities, describes country-specific clinical HCC experience and practice, and considers future needs and the potential for HCC collaborations across the region. Liver Cancer in the Middle East is a useful resource for clinicians seeking insight into the second highest cause of death from cancer worldwide, governments planning social and medical services for their peoples, as well as for international aid agencies prioritizing donations.
988 _aSpringer_Medicine_2021
650 7 _2embne
_9413204
_aHígado
_xCáncer
700 1 _aCarr, Brian I.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783030787363
776 0 8 _iPrinted edition:
_z9783030787387
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-78737-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b02/2022
_dz
_eb
_zSI